Battle of the Biologics in Ulcerative Colitis

<![CDATA[]]>(MedPage Today) — An update of a 2017 network meta-analysis found infliximab (Remicade) to be more effective than other biologics for biologic-naive patients with moderate to severely active ulcerative colitis (UC).
A total of 16 trials published…

Source link

Related posts

Effectiveness of Z-score of log-transformed A Body Shape Index (LBSIZ) in predicting cardiovascular disease in Korea: the Korean Genome and Epidemiology Study


FDA approves ConvertX Biliary Stent System for bile duct obstructions


Is tenofovir associated with lower risk of hepatocellular carcinoma in patients with chronic hepatitis B compared to entecavir?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World